Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Resectable Liver and Intrahepatic Bile Duct Carcinoma”

87 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 87 results

Testing effectiveness (Phase 2)Study completedNCT03579771
What this trial is testing

Gemcitabine, Cisplatin, and Nab-Paclitaxel Before Surgery in Patients With High-Risk Liver Bile Duct Cancer

Who this might be right for
Resectable CholangiocarcinomaStage IB Intrahepatic Cholangiocarcinoma AJCC v8Stage II Intrahepatic Cholangiocarcinoma AJCC v8+3 more
Emory University 30
Testing effectiveness (Phase 2)Study completedNCT00040898
What this trial is testing

Sho-Saiko-To Following Removal of Liver Cancer By Embolization in Treating Patients With Liver Cancer That Cannot Be Surgically Removed

Who this might be right for
Liver Cancer
Memorial Sloan Kettering Cancer Center
Not applicableUnknownNCT05609448
What this trial is testing

MRI-guided Holmium-166 Radioembolization

Who this might be right for
Primary Liver CancerNon-Resectable Hepatocellular Carcinoma
Radboud University Medical Center 15
Testing effectiveness (Phase 2)Looking for participantsNCT05265208
What this trial is testing

Selective Internal Radiation Therapy and Capecitabine (Chemotherapy) Treatment for Liver Cancer

Who this might be right for
Resectable Intrahepatic Cholangiocarcinoma
Center Eugene Marquis 62
Not applicableStudy completedNCT00081094
What this trial is testing

Positron Emission Tomography Using Carbon-11 Acetate and Fludeoxyglucose F 18 in Detecting Hepatocellular Carcinoma (Liver Cancer) in Patients With Known or Suspected Liver Cancer

Who this might be right for
Liver Cancer
Washington University School of Medicine 31
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07684040
What this trial is testing

Combination Therapy in Patients With Resectable Liver Cancer

Who this might be right for
Liver Cancer (Primary and Metastatic)
Affiliated Hospital of Guangdong Medical University 68
Testing effectiveness (Phase 2)Study completedNCT01395030
What this trial is testing

PET/CT in Diagnosing Patients With Liver Cancer Undergoing Surgical Resection

Who this might be right for
Adult Hepatocellular CarcinomaLocalized Resectable Adult Liver Carcinoma
Queen's Medical Center 64
Large-scale testing (Phase 3)Study completedNCT00870558
What this trial is testing

Iodine I 131 Ethiodized Oil in Preventing Recurrent Cancer in Patients Who Have Undergone Treatment for Liver Cancer

Who this might be right for
Liver Cancer
Hospices Civils de Lyon 120
Testing effectiveness (Phase 2)Ended earlyNCT00023946
What this trial is testing

BMS-247550 in Treating Patients With Liver or Gallbladder Cancer

Who this might be right for
Adult Primary Cholangiocellular CarcinomaAdult Primary Hepatocellular CarcinomaAdvanced Adult Primary Liver Cancer+11 more
National Cancer Institute (NCI) 50
Large-scale testing (Phase 3)WithdrawnNCT00238160
What this trial is testing

Surgery With or Without Hepatic Arterial Chemotherapy in Treating Patients With Liver Cancer

Who this might be right for
Localized Resectable Adult Primary Liver CancerStage III Childhood Liver Cancer
Kyoto University
Testing effectiveness (Phase 2)Study completedNCT01835223
What this trial is testing

Tivozanib in Treating Patients With Liver Cancer That Is Metastatic or Cannot Be Removed by Surgery

Who this might be right for
Advanced Adult Hepatocellular CarcinomaNon-Resectable Hepatocellular Carcinoma
Roswell Park Cancer Institute 33
Early research (Phase 1)Active Not RecruitingNCT05701488
What this trial is testing

SIRT With Tremelimumab and Durvalumab for Resectable HCC

Who this might be right for
Resectable Hepatocellular CarcinomaHepatocellular CarcinomaHepatocellular Cancer
Jiping Wang, MD, PhD 20
Testing effectiveness (Phase 2)Study completedNCT00005629
What this trial is testing

Vaccine Therapy in Treating Patients With Liver Cancer

Who this might be right for
Liver Cancer
Jonsson Comprehensive Cancer Center 6
Not applicableLooking for participantsNCT06731998
What this trial is testing

Optimal Perioperative Pain Control in Minimally Invasive Abdominal Cancer Surgery

Who this might be right for
Oncologic SurgeryCancerCancer Surgery+8 more
Allegheny Singer Research Institute (also known as Allegheny Health Network Research Institute) 48
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07363356
What this trial is testing

Drug Sensitivity Testing-Based Tumor Organoids to Guide Adjuvant Therapy After Hepatectomy for Primary Liver Cancer

Who this might be right for
Hepatocellular Carcinoma Resectable
Eastern Hepatobiliary Surgery Hospital 56
Testing effectiveness (Phase 2)Ended earlyNCT01009801
What this trial is testing

Transarterial Chemoembolization With Doxorubicin With or Without Everolimus in Treating Patients With Liver Cancer

Who this might be right for
Liver Cancer
Swiss Cancer Institute 27
Not applicableStudy completedNCT02072486
What this trial is testing

Sorafenib Tosylate in Treating Patients With Liver Cancer That Cannot Be Removed by Surgery

Who this might be right for
Advanced Adult Hepatocellular CarcinomaLocalized Non-Resectable Adult Hepatocellular CarcinomaStage III Childhood Hepatocellular Carcinoma+6 more
Roswell Park Cancer Institute 30
Testing effectiveness (Phase 2)UnknownNCT01182272
What this trial is testing

Sorafenib Tosylate in Treating Patients With Liver Cancer That Can Be Removed by Surgery

Who this might be right for
Liver Cancer
GERCOR - Multidisciplinary Oncology Cooperative Group 36
Large-scale testing (Phase 3)Study completedNCT00016380
What this trial is testing

Ondansetron With/Out Dexamethasone to Prevent Vomiting in Patients Receiving Radiation to the Upper Abdomen

Who this might be right for
Cancer
NCIC Clinical Trials Group 211
Not applicableUnknownNCT06214533
What this trial is testing

Celiac plExus Block to Reduce OpioID Consumption Following Hepato-pancreato-biliary Mini-invasive Surgery

Who this might be right for
Pancreatic Ductal AdenocarcinomaLiver, Cancer of, Primary Resectable
Sixth Affiliated Hospital, Sun Yat-sen University 60
Next Page